The effect of transdermal estradiol on the conjunctiva in postmenopausal women

Eur J Obstet Gynecol Reprod Biol. 1997 Mar;72(1):93-6. doi: 10.1016/s0301-2115(97)85911-8.

Abstract

Objective: To evaluate the effect of hormonal replacement therapy on the conjunctiva in postmenopausal women.

Study design: A prospective clinical study in the setting of a tertiary-care university hospital. Eleven postmenopausal women received hormonal replacement therapy (transdermal estradiol or transdermal estradiol plus medroxyprogesterone acetate) for 4 months. Serum estradiol levels as well as vaginal and conjunctival maturation value (a cytological parameter) were measured before and after the treatment. Data were analysed using the Wilcoxon matched pairs signed-Rank test.

Results: A significant increase of serum estradiol levels (P < 0.01) and of vaginal maturation value (P < 0.01) were found. Cytological maturation changes in conjunctival epithelium were also observed. These changes, although mild, were statistically significant (P < 0.01).

Conclusion: These data support the view that the hormonal replacement therapy induces cytological maturation changes in conjunctival epithelium in postmenopausal women.

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Conjunctiva / cytology*
  • Conjunctiva / drug effects
  • Epithelial Cells
  • Epithelium / drug effects
  • Estradiol / administration & dosage*
  • Estradiol / blood
  • Estradiol / therapeutic use
  • Female
  • Humans
  • Medroxyprogesterone Acetate / administration & dosage
  • Medroxyprogesterone Acetate / therapeutic use
  • Middle Aged
  • Postmenopause*
  • Vaginal Smears

Substances

  • Estradiol
  • Medroxyprogesterone Acetate